Position in BOLD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$206,250
-$18,750 QoQ
Shares Held
187,500
0.0% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,680 across 116 Biotechnology names. BOLD ranks #88 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in BOLD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $206,250 | 187,500 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $225,000 | 187,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $230,625 | 187,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $189,375 | 187,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $283,125 | 187,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $543,750 | 187,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $650,625 | 187,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,411,334 | 364,686 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,343,750 | 375,000 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||